MedPath
NMPA Approval

Cetuximab Solution for Infusion

国药准字SJ20171039

October 10, 2022

S20171039

Drug Information

西妥昔单抗注射液

爱必妥

注射剂

100mg/20ml/瓶

生物制品

October 10, 2022

October 9, 2027

Company Information

Applicant Company

Merck Europe BV

Gustav Mahlerplein 102, 1082 MA Amsterdam, The Netherlands

Manufacturing Company

Frankfurter Straβe 250, 64293 Darmstadt, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

西妥昔单抗注射液 - NMPA 批准文号 | MedPath